ATA88084A - Vorrichtung zur kontrollierten abgabe eines wirkstoffes - Google Patents

Vorrichtung zur kontrollierten abgabe eines wirkstoffes

Info

Publication number
ATA88084A
ATA88084A AT0088084A AT88084A ATA88084A AT A88084 A ATA88084 A AT A88084A AT 0088084 A AT0088084 A AT 0088084A AT 88084 A AT88084 A AT 88084A AT A88084 A ATA88084 A AT A88084A
Authority
AT
Austria
Prior art keywords
active substance
controlled delivery
delivery
controlled
substance
Prior art date
Application number
AT0088084A
Other languages
English (en)
Other versions
AT397180B (de
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23961585&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATA88084(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Priority to AT150789A priority Critical patent/AT394944B/de
Publication of ATA88084A publication Critical patent/ATA88084A/de
Application granted granted Critical
Publication of AT397180B publication Critical patent/AT397180B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
AT0088084A 1983-05-11 1984-03-15 Vorrichtung zur kontrollierten abgabe eines wirkstoffes AT397180B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT150789A AT394944B (de) 1983-05-11 1989-06-20 Verfahren zur herstellung einer vorrichtung zur abgabe eines wirkstoffes, insbesondere eines heilmittels, an eine waesserige verwendungsumgebung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49376083A 1983-05-11 1983-05-11

Publications (2)

Publication Number Publication Date
ATA88084A true ATA88084A (de) 1993-07-15
AT397180B AT397180B (de) 1994-02-25

Family

ID=23961585

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0088084A AT397180B (de) 1983-05-11 1984-03-15 Vorrichtung zur kontrollierten abgabe eines wirkstoffes

Country Status (20)

Country Link
JP (1) JPS6041609A (de)
AT (1) AT397180B (de)
AU (1) AU566110B2 (de)
BE (1) BE898819A (de)
CA (1) CA1222950A (de)
CH (1) CH669329A5 (de)
DE (1) DE3417113A1 (de)
DK (1) DK163910C (de)
ES (1) ES532018A0 (de)
FR (1) FR2545721B1 (de)
GB (1) GB2140687B (de)
IE (1) IE56515B1 (de)
IL (1) IL71727A (de)
IT (1) IT1178911B (de)
MX (1) MX163518B (de)
NL (1) NL192250C (de)
NO (1) NO170834C (de)
NZ (1) NZ206600A (de)
SE (1) SE455918B (de)
ZA (1) ZA842422B (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
US4600773A (en) * 1983-12-01 1986-07-15 Eli Lilly And Company Crystalline cephalexin hydrochloride monohydrate
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
ES8800043A1 (es) * 1985-08-16 1987-10-16 Alza Corp Un dispositivo distribuidor para descargar una formulacion de agente beneficioso a un entorno de uso
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
US4704118A (en) * 1985-08-16 1987-11-03 Alza Corporation Ruminant dispensing device with thermo-activated memory
US4723957A (en) * 1986-02-07 1988-02-09 Alza Corp. System for delivering drug with enhanced bioacceptability
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
DE3871343D1 (de) * 1987-11-25 1992-06-25 American Cyanamid Co System fuer die verzoegerte (kontrollierte) freisetzung von substituierten dihydropyridin-calciumantagonisten.
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
GR1000270B (el) * 1988-09-30 1992-05-12 Alza Corp Μορφη δοσολογιας για θεραπεια καρδιαγγειακων ασθενειων.
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5067960A (en) * 1989-12-06 1991-11-26 Medtronic, Inc. Muscle fitness detection by colorimetry
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5081161A (en) * 1990-06-15 1992-01-14 E. I. Du Pont De Nemours And Company Process for making shaped articles of a thermoplastic resin having a microcellular structure
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
ATE118345T1 (de) * 1990-08-07 1995-03-15 Pfizer Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen.
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
CA2089738C (en) * 1990-09-28 1997-01-21 Avinash Govind Thombre Dispensing device containing a hydrophobic medium
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
EP0612519B1 (de) * 1993-02-23 2001-04-04 Wolfgang Dr. Werner Die Verwendung eines Calciumpräparates in einem Medikament zur Behandlung von an Hypocalcämie leidenden Milchkühen
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
US5948787A (en) 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
EP1337244A4 (de) * 2000-10-30 2006-01-11 Euro Celtique Sa Hydrocodon-formulierungen mit kontrollierter freisetzung
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE10300111A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
BRPI0414305A (pt) * 2003-09-19 2006-11-07 Sun Pharmaceutical Ind Ltd sistema de liberação de drogas por via oral
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (de) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prophylaxe und Behandlung von thrombolischen Erkrankungen
DE102005031577A1 (de) * 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
BRPI0616801B8 (pt) 2005-10-04 2021-05-25 Bayer Healthcare Ag "forma polimórfica de 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofenocarboxamida, seus processos de preparação e seus usos, medicamento, e processo para prevenção de coagulação de sangue in vitro
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
WO2010139111A1 (en) * 2009-06-02 2010-12-09 Dow Global Technologies Inc. Sustained release dosage form
DE102011007272A1 (de) 2011-04-13 2012-10-18 Bayer Pharma Aktiengesellschaft Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung
WO2013167453A1 (en) 2012-05-07 2013-11-14 Bayer Pharma Aktiengesellschaft Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil
UY34856A (es) 2012-07-03 2013-12-31 Bayer Pharma AG Formas de presentación farmacéuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4- morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida
JP5941117B2 (ja) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー 徐放製剤
CA3107174A1 (en) 2018-07-24 2020-01-30 Bayer Aktiengesellschaft Pharmaceutical dosage form which can be administered orally and has modified release
SG11202100369WA (en) 2018-07-24 2021-02-25 Bayer Ag Pharmaceutical dosage form which can be administered orally and has modified release
US10905667B2 (en) 2018-07-24 2021-02-02 Bayer Pharma Aktiengesellschaft Orally administrable modified-release pharmaceutical dosage form

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL38538A (en) * 1971-01-13 1974-09-10 Alza Corp Osmotic dispenser
US3977404A (en) * 1975-09-08 1976-08-31 Alza Corporation Osmotic device having microporous reservoir
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device

Also Published As

Publication number Publication date
IL71727A (en) 1989-01-31
GB2140687A (en) 1984-12-05
DK99784D0 (da) 1984-02-24
SE8402512D0 (sv) 1984-05-09
NL192250B (nl) 1996-12-02
DE3417113C2 (de) 1989-02-02
GB2140687B (en) 1987-03-18
CH669329A5 (de) 1989-03-15
DK99784A (da) 1984-11-12
SE8402512L (sv) 1984-11-12
SE455918B (sv) 1988-08-22
AT397180B (de) 1994-02-25
CA1222950A (en) 1987-06-16
AU566110B2 (en) 1987-10-08
GB8334189D0 (en) 1984-02-01
FR2545721A1 (fr) 1984-11-16
IT1178911B (it) 1987-09-16
NO840248L (no) 1984-11-12
ES8503503A1 (es) 1985-03-01
NO170834B (no) 1992-09-07
IL71727A0 (en) 1984-09-30
IT8467283A0 (it) 1984-03-23
JPS6041609A (ja) 1985-03-05
ES532018A0 (es) 1985-03-01
NL192250C (nl) 1997-04-03
DE3417113A1 (de) 1984-11-15
BE898819A (fr) 1984-05-30
MX163518B (es) 1992-05-25
DK163910C (da) 1992-09-14
NO170834C (no) 1992-12-16
IE56515B1 (en) 1991-08-28
NL8401470A (nl) 1984-12-03
NZ206600A (en) 1987-01-23
DK163910B (da) 1992-04-21
FR2545721B1 (fr) 1987-11-06
ZA842422B (en) 1984-11-28
JPH0575725B2 (de) 1993-10-21
AU2251183A (en) 1984-11-15
IT8467283A1 (it) 1985-09-23
IE840010L (en) 1984-11-11

Similar Documents

Publication Publication Date Title
ATA88084A (de) Vorrichtung zur kontrollierten abgabe eines wirkstoffes
DE3586713D1 (de) Vorrichtung zur kontrollierten abgabe von arzneimittelwirkstoffen.
ATA72784A (de) Osmotische vorrichtung für die abgabe eines wirkstoffes
AT400296B (de) Dosierungsform zur schnellen abgabe eines wirkstoffes gefolgt von einer langsamen abgabe eines wirkstoffes
DE3580924D1 (de) Vorrichtung zur verzoegerten freigabe von wirksubstanzen.
DD256416A3 (de) Vorrichtung zur blutreinigung
DE4391418T1 (de) Vorrichtung zur elektrochemischen Behandlung von Wasser
AT387554B (de) Vorrichtung zur gefahrlosen entleerung von spraydosen
ATE4234T1 (de) Vorrichtung zur dosierten abgabe eines wirkstoffs.
DE3678900D1 (de) Vorrichtung zur kontinuierlichen behandlung von viskosem material.
DE68919007T2 (de) Verfahren und Vorrichtung zur präzisen Lötzinnzuführung.
FI902527A0 (fi) Laite aineen sumuttamiseksi säiliöstä
DE3689168T2 (de) Vorrichtung zur Regulierung der Konzentration einer wässrigen Alkohollösung.
DE3875595D1 (de) Bolusfoermige vorrichtung zur gesteuerten wirkstofffreisetzung.
DE3861977D1 (de) Vorrichtung zur dosierbaren klebstoff-applikation.
DE3767694D1 (de) Vorrichtung zur keratotomie der cornea.
ATA151683A (de) Vorrichtung zur farbprofilabhaengigen feuchtmittelregelung
AT377701B (de) Vorrichtung zur laengsverstellung
DE69002034D1 (de) Vorrichtung mit gesteuerter wirkstoffabgabe.
ATA25488A (de) Vorrichtung zur konservierung von fluessigen produkten
GR80449B (en) Method for the preparation of an absorbent deposit of active substances based on collagen
DE3580969D1 (de) Einrichtung zur halterung eines gegenstandes.
AT389589B (de) Einrichtung zur wahlweisen beschickung eines analysengeraetes
DE58903842D1 (de) Vorrichtung zur aufbereitung fluessiger bis duennbreiiger medien.
ATA500481A (de) Vorrichtung fuer den vorschub von stabmaterial

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee
ELA Expired due to lapse of time
MK07 Expiry

Effective date: 20110715